Grunenthal - Crunchbase Company Profile & Funding

Q: When was the last funding round for Grunenthal?

Grunenthal closed its last funding round on obfuscated from a Debt Financing round.

Q: How much funding has Grunenthal raised to date?

Grunenthal has raised obfuscated.

Overview

Grunenthal

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Grunenthal

CB Rank

55060

Grunenthal is a pharmaceutical company that specializes in pain management and related diseases.

Founded

obfuscation

Private

Debt Financing

Aachen, Nordrhein-Westfalen, Germany

1001-5000

www.grunenthal.de

Health Care

Medical

Pharmaceutical

Funding Rounds

Debt Financing

OBF

obfuscation

Key People

Jan Adams: Chief Commercial Officer and Member of the Corporate Executive Board

Details

Legal Name

Grunenthal GmbH

Operating Status

Active

Company Type

For Profit

Founders

Hermann Wirtz, Sr

Phone Number

+49 241 5690

Contact Email

dataprivacy.de@grunenthal.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Abstral

A fast-acting medication for managing breakthrough cancer pain in adult patients already receiving opioid therapy.

PecFent

An opioid analgesic used for managing severe pain in patients requiring opioid treatment.

Research & Development

Grunenthal is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Grunenthal	—	obfuscated obfuscation	—	Debt Financing